Logo image of BWSN

BABCOCK & WILCOX ENTERPR - BW 8 1/8 02/28/26 (BWSN) Stock Fundamental Analysis

NYSE:BWSN - New York Stock Exchange, Inc. - US05614L3087 - Currency: USD

20.9  +0.9 (+4.5%)

Fundamental Rating

2

BWSN gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 94 industry peers in the Electrical Equipment industry. Both the profitability and financial health of BWSN have multiple concerns. BWSN does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

3

1. Profitability

1.1 Basic Checks

BWSN had negative earnings in the past year.
BWSN had a negative operating cash flow in the past year.
BWSN had negative earnings in 4 of the past 5 years.
BWSN had a negative operating cash flow in each of the past 5 years.
BWSN Yearly Net Income VS EBIT VS OCF VS FCFBWSN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -200M -400M -600M

1.2 Ratios

BWSN has a Return On Assets (-11.11%) which is comparable to the rest of the industry.
Looking at the Return On Invested Capital, with a value of 11.64%, BWSN belongs to the top of the industry, outperforming 88.30% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for BWSN is significantly below the industry average of 10.06%.
The last Return On Invested Capital (11.64%) for BWSN is above the 3 year average (3.67%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA -11.11%
ROE N/A
ROIC 11.64%
ROA(3y)-13.87%
ROA(5y)-8.19%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)3.67%
ROIC(5y)3.7%
BWSN Yearly ROA, ROE, ROICBWSN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500 1K

1.3 Margins

With a decent Operating Margin value of 4.44%, BWSN is doing good in the industry, outperforming 70.21% of the companies in the same industry.
In the last couple of years the Operating Margin of BWSN has grown nicely.
Looking at the Gross Margin, with a value of 24.40%, BWSN is in line with its industry, outperforming 52.13% of the companies in the same industry.
BWSN's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 4.44%
PM (TTM) N/A
GM 24.4%
OM growth 3Y9.27%
OM growth 5Y41.42%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.18%
GM growth 5Y5.75%
BWSN Yearly Profit, Operating, Gross MarginsBWSN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 -40 -60

More info and screens

0

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), BWSN is creating some value.
BWSN has more shares outstanding than it did 1 year ago.
BWSN has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, BWSN has a worse debt to assets ratio.
BWSN Yearly Shares OutstandingBWSN Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M
BWSN Yearly Total Debt VS Total AssetsBWSN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

2.2 Solvency

BWSN has an Altman-Z score of -0.99. This is a bad value and indicates that BWSN is not financially healthy and even has some risk of bankruptcy.
With a Altman-Z score value of -0.99, BWSN perfoms like the industry average, outperforming 40.43% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -0.99
ROIC/WACC1.34
WACC8.66%
BWSN Yearly LT Debt VS Equity VS FCFBWSN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M 600M

2.3 Liquidity

BWSN has a Current Ratio of 0.94. This is a bad value and indicates that BWSN is not financially healthy enough and could expect problems in meeting its short term obligations.
The Current ratio of BWSN (0.94) is worse than 73.40% of its industry peers.
A Quick Ratio of 0.73 indicates that BWSN may have some problems paying its short term obligations.
BWSN has a worse Quick ratio (0.73) than 70.21% of its industry peers.
Industry RankSector Rank
Current Ratio 0.94
Quick Ratio 0.73
BWSN Yearly Current Assets VS Current LiabilitesBWSN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

More info and screens

3

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 15.57% over the past year.
BWSN shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -29.45%.
The Revenue has been decreasing by -3.54% on average over the past years.
EPS 1Y (TTM)15.57%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%50%
Revenue 1Y (TTM)-29.45%
Revenue growth 3Y-0.28%
Revenue growth 5Y-3.54%
Sales Q2Q%-12.7%

3.2 Future

Based on estimates for the next years, BWSN will show a very strong growth in Earnings Per Share. The EPS will grow by 28.35% on average per year.
The Revenue is expected to grow by 0.82% on average over the next years.
EPS Next Y82.21%
EPS Next 2Y42.43%
EPS Next 3Y28.35%
EPS Next 5YN/A
Revenue Next Year-11.58%
Revenue Next 2Y-1.31%
Revenue Next 3Y0.82%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
BWSN Yearly Revenue VS EstimatesBWSN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 500M 1B 1.5B
BWSN Yearly EPS VS EstimatesBWSN Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 -20 -40

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for BWSN. In the last year negative earnings were reported.
A Price/Forward Earnings ratio of 676.38 indicates a quite expensive valuation of BWSN.
Based on the Price/Forward Earnings ratio, BWSN is valued a bit cheaper than 62.77% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 22.25. BWSN is valued rather expensively when compared to this.
Industry RankSector Rank
PE N/A
Fwd PE 676.38
BWSN Price Earnings VS Forward Price EarningsBWSN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 200 400 600

4.2 Price Multiples

BWSN's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. BWSN is cheaper than 65.96% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 56.34
BWSN Per share dataBWSN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4 -4 6

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates BWSN does not grow enough to justify the current Price/Earnings ratio.
A more expensive valuation may be justified as BWSN's earnings are expected to grow with 28.35% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y42.43%
EPS Next 3Y28.35%

More info and screens

5

5. Dividend

5.1 Amount

BWSN has a Yearly Dividend Yield of 9.72%, which is a nice return.
Compared to an average industry Dividend Yield of 4.38, BWSN pays a better dividend. On top of this BWSN pays more dividend than 97.87% of the companies listed in the same industry.
Compared to an average S&P500 Dividend Yield of 2.39, BWSN pays a better dividend.
Industry RankSector Rank
Dividend Yield 9.72%

5.2 History

BWSN has been paying a dividend for over 5 years, so it has already some track record.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
BWSN Yearly Dividends per shareBWSN Yearly Dividends per shareYearly Dividends per share 2021 2022 2023 2024 2025 0.5 1 1.5 2

5.3 Sustainability

BWSN has negative earnings and hence a negative payout ratio. The dividend may be in danger.
DP-23.23%
EPS Next 2Y42.43%
EPS Next 3Y28.35%
BWSN Yearly Income VS Free CF VS DividendBWSN Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -200M -400M -600M

More info and screens

BABCOCK & WILCOX ENTERPR - BW 8 1/8 02/28/26

NYSE:BWSN (6/6/2025, 8:04:01 PM)

20.9

+0.9 (+4.5%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryElectrical Equipment
Earnings (Last)05-12 2025-05-12/amc
Earnings (Next)08-06 2025-08-06/amc
Inst Owners75.24%
Inst Owner ChangeN/A
Ins Owners3.59%
Ins Owner ChangeN/A
Market Cap2.06B
Analysts80
Price Target49.49 (136.79%)
Short Float %0.13%
Short Ratio2.73
Dividend
Industry RankSector Rank
Dividend Yield 9.72%
Yearly Dividend0.2
Dividend Growth(5Y)N/A
DP-23.23%
Div Incr Years0
Div Non Decr Years0
Ex-Date04-15 2025-04-15 (0.5078)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-2379.98%
Min EPS beat(2)-4779.86%
Max EPS beat(2)19.9%
EPS beat(4)2
Avg EPS beat(4)-2023.49%
Min EPS beat(4)-4779.86%
Max EPS beat(4)449.52%
EPS beat(8)2
Avg EPS beat(8)-1313.75%
EPS beat(12)2
Avg EPS beat(12)-919.18%
EPS beat(16)5
Avg EPS beat(16)-648.14%
Revenue beat(2)1
Avg Revenue beat(2)-0.16%
Min Revenue beat(2)-8.5%
Max Revenue beat(2)8.19%
Revenue beat(4)1
Avg Revenue beat(4)-4.11%
Min Revenue beat(4)-11.29%
Max Revenue beat(4)8.19%
Revenue beat(8)2
Avg Revenue beat(8)-3.74%
Revenue beat(12)5
Avg Revenue beat(12)-0.79%
Revenue beat(16)7
Avg Revenue beat(16)-0.76%
PT rev (1m)-70.02%
PT rev (3m)-49.15%
EPS NQ rev (1m)-100%
EPS NQ rev (3m)-100%
EPS NY rev (1m)-33.34%
EPS NY rev (3m)-3633.4%
Revenue NQ rev (1m)-8.23%
Revenue NQ rev (3m)-12.81%
Revenue NY rev (1m)1.01%
Revenue NY rev (3m)-6.45%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 676.38
P/S 2.98
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA 56.34
EPS(TTM)-0.97
EYN/A
EPS(NY)0.03
Fwd EY0.15%
FCF(TTM)-1.26
FCFYN/A
OCF(TTM)-1.14
OCFYN/A
SpS7.02
BVpS-3.08
TBVpS-4.1
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -11.11%
ROE N/A
ROCE 14.73%
ROIC 11.64%
ROICexc 12.98%
ROICexgc 28.23%
OM 4.44%
PM (TTM) N/A
GM 24.4%
FCFM N/A
ROA(3y)-13.87%
ROA(5y)-8.19%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)3.67%
ROIC(5y)3.7%
ROICexc(3y)4.08%
ROICexc(5y)4.44%
ROICexgc(3y)6%
ROICexgc(5y)6.49%
ROCE(3y)4.64%
ROCE(5y)4.69%
ROICexcg growth 3Y18.44%
ROICexcg growth 5Y33.31%
ROICexc growth 3Y21.33%
ROICexc growth 5Y31.59%
OM growth 3Y9.27%
OM growth 5Y41.42%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.18%
GM growth 5Y5.75%
F-Score3
Asset Turnover0.96
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA 5.97
Cap/Depr 84.64%
Cap/Sales 1.76%
Interest Coverage 0.78
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.94
Quick Ratio 0.73
Altman-Z -0.99
F-Score3
WACC8.66%
ROIC/WACC1.34
Cap/Depr(3y)56.25%
Cap/Depr(5y)50.83%
Cap/Sales(3y)1.46%
Cap/Sales(5y)1.35%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)15.57%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%50%
EPS Next Y82.21%
EPS Next 2Y42.43%
EPS Next 3Y28.35%
EPS Next 5YN/A
Revenue 1Y (TTM)-29.45%
Revenue growth 3Y-0.28%
Revenue growth 5Y-3.54%
Sales Q2Q%-12.7%
Revenue Next Year-11.58%
Revenue Next 2Y-1.31%
Revenue Next 3Y0.82%
Revenue Next 5YN/A
EBIT growth 1Y14.73%
EBIT growth 3Y8.96%
EBIT growth 5Y36.41%
EBIT Next Year10.85%
EBIT Next 3Y18.11%
EBIT Next 5YN/A
FCF growth 1Y-682.47%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-7384.93%
OCF growth 3YN/A
OCF growth 5YN/A